Solara Active Pharma Sciences Ltd Share Price

Overview

Solara Active Pharma Sciences Ltd share price is currently ₹624.41, up by ₹6.28 (1.02%) from its previous closing price of ₹618.13. The share price has gained 24.62% over the past month and gained 4.15% over the past year. The stock's 52-week low and high are ₹413.10 and ₹700.72, respectively. Solara Active Pharma Sciences Ltd has a market capitalisation of ₹ 2,970.00 Cr. The share price was last updated on 25 Aug 2026, 03:53 PM IST.

Solara Active Pharma Sciences Ltd

SOLARA

₹0.00

₹6.28

1.02%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 03:53:32 pm IST

Market Data

Open Price

₹623.99

Prev. Close

₹618.13

₹618.59

Day Low

₹648.48

Day High

₹413.10

52 Week Low

₹700.72

52 Week High

HealthcarePharmaceuticals & Drugs

CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

-975.64

Sector PE

42.03

PB Ratio

2.30

Sector PB

5.83

EPS

-0.64

Dividend Yield

0.00

Today's Volume

347.576 K

5 Day Avg. Volume

1.744 M

PEG Ratio

-9.75

Market Cap.

₹ 2,970.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Aditya Birla Sun Life Flexi Cap Fund - Regular Plan - Growth	4.20 Lac	4.20 Lac no change
Motilal Oswal BSE Healthcare ETF	611	624 (2.13%)
Bandhan BSE Healthcare Index Fund - Regular Plan - Growth	313	335 (7.03%)
Motilal Oswal BSE 1000 Index Fund - Regular Plan - Growth	69	68 (1.45%)

About Solara Active Pharma Sciences Ltd 👋

Solara Active Pharma Sciences Limited is an India-based global, pureplay active pharmaceutical ingredients (API) company. The Company is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product category includes Albendazole, Aprepitant (Antiemetic), Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, Zileuton and others. Its research and development (R&D) product category includes Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, Tranexamic Acid, Sucroferric Oxyhydroxide and others. Its business is spread across 70 countries with operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. It has one R&D center in Chennai.